☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Liver Fibrosis
Takeda Signs a License Agreement with Genevant to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis
March 16, 2021
Genentech Acquires Jecure Therapeutics for its Preclinical Stage NLRP3 inhibitors
November 29, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
